scholarly journals P1-516 High risk behaviours and its association with hepatitis b infection among Malaysian antenatal mothers

2011 ◽  
Vol 65 (Suppl 1) ◽  
pp. A209-A210
Author(s):  
K. Shamsuddin ◽  
L. Z. Marmuji ◽  
Z. A. Mahdy ◽  
M. A. Kamaluddin
1993 ◽  
Vol 6 (3) ◽  
pp. 211-229 ◽  
Author(s):  
L B Polish ◽  
M Gallagher ◽  
H A Fields ◽  
S C Hadler

Hepatitis delta virus, discovered in 1977, requires the help of hepatitis B virus to replicate in hepatocytes and is an important cause of acute, fulminant, and chronic liver disease in many regions of the world. Because of the helper function of hepatitis delta virus, infection with it occurs either as a coinfection with hepatitis B or as a superinfection of a carrier of hepatitis B surface antigen. Although the mechanisms of transmission are similar to those of hepatitis B virus, the patterns of transmission of delta virus vary widely around the world. In regions of the world in which hepatitis delta virus infection is not endemic, the disease is confined to groups at high risk of acquiring hepatitis B infection and high-risk hepatitis B carriers. Because of the propensity of this viral infection to cause fulminant as well as chronic liver disease, continued incursion of hepatitis delta virus into areas of the world where persistent hepatitis B infection is endemic will have serious implications. Prevention depends on the widespread use of hepatitis B vaccine. This review focuses on the molecular biology and the clinical and epidemiologic features of this important viral infection.


Author(s):  
Karoney Mercy Jelagat ◽  
Some Fatuma Faraj ◽  
Dip Hellen Irusa Lukhaka ◽  
Dip Eric Wang'welo ◽  
Murgor Laban Kipkemei ◽  
...  

2007 ◽  
Vol 34 (11) ◽  
pp. 917-922 ◽  
Author(s):  
Beryl A. Koblin ◽  
Guozhen Xu ◽  
Debbie Lucy ◽  
Verna Robertson ◽  
Sebastian Bonner ◽  
...  

1993 ◽  
Vol 159 (8) ◽  
pp. 562-563 ◽  
Author(s):  
Sandra C Thompson ◽  
Elaine Stevenson ◽  
Rory Wilby ◽  
Nick Crofts

1991 ◽  
Vol 7 (3) ◽  
pp. 256-262 ◽  
Author(s):  
Evi J. Hatziandreu ◽  
Angelos Hatzakis ◽  
Stefanos Hatziyannis ◽  
Mark A. Kane ◽  
Milton C. Weinstein

AbstractWe evaluated the cost-effectiveness of (a) a vaccination program for the prevention of hepatitis B; and (b) the two commercially available vaccines (Merck Sharp and Dohme; Pasteur Institute) in Greece, a country of intermediate endemicity. We examined cases of hepatitis-B infection prevented and the expected medical costs among the high-risk groups of medical and nursing students, hospital personnel, and the general population. Employing a vaccination program reduces considerably the risk of infection, especially in the high-risk groups, while it increases the total cost. The vaccines are very comparable in terms of both health and economic outcomes. Sensitivity analysis indicated that vaccine cost, incidence of hepatitis B, and compliance were the key factors for the choice of (a) whether to undertake an extensive program to prevent hepatitis-B infection and its chronic sequelae; and (b) which vaccine to administer.


Author(s):  
Vasantha Mallika M. C. ◽  
Sivaanusuya S.

Background: Hepatitis B infection is a serious global public health problem. About two billion people are infected with hepatitis B Virus (HBV) all over the world. The prevalence of HBV infection in India is 4%(2%-8%) with more prevalence among health care workers. Medical students represent a group that is at high-risk for acquiring and spreading hepatitis B infection. Despite increasing prevalence of HBV infection, there is paucity of knowledge, attitude and practice on HBV among medical students. Objective of the study was to assess the knowledge, attitude and practices on prevention of hepatitis B infection among medical students of Sree Mookambika Institute of Medical Sciences, Kulasekharam.Methods: A cross sectional study was conducted among 205 MBBS students using a pretested self-administered questionnaire for assessing the knowledge, attitude, and practice on prevention of HBV infection after obtaining informed consent from the participants.Results: Among 205 MBBS students, correct response towards Knowledge, Attitude, and Practices were given by 77.07%, 77.56%, and 76.59% respectively, 79.5% of the students were fully vaccinated; 20.5% were partially vaccinated against Hepatitis B Virus infection.Conclusions: The medical students are at a very high risk of contracting HBV infection during their training period in view of low HBV vaccine uptake rate and high chance of accidental exposure to blood infected with HBV. Creating awareness among medical students on various aspects of Hepatitis B infection through health education programs before their exposure in medical colleges and subjecting them to active immunization against HBV are mandatory to control the spread of Hepatitis B viral infection.


2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Abdolmajid Khosravani ◽  
Bahador Sarkari ◽  
Halimeh Negahban ◽  
Asghar Sharifi ◽  
Mehdi Akbartabar Toori ◽  
...  

1993 ◽  
Vol 14 (9) ◽  
pp. 335-335
Author(s):  
Caroline Breese Hall

Concerns and confusion have risen over the recent recommendations for universal immunization to prevent infection with hepatitis B virus (HBV) published by the American Academy of Pediatrics (AAP)1 and the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control (CDC).2 Both of these recommendations, collaboratively developed, recommend universal immunization of infants against HBV as well as the continued previous strategies of screening all pregnant women for HBsAg positivity and immunizing all high-risk groups. The AAP further recommends that all adolescents be immunized in recognition of the increased risk and rate of acquiring HBV in this age group.


2012 ◽  
Vol 12 (7) ◽  
pp. 467-468 ◽  
Author(s):  
Amitis Ramezani ◽  
Mohammad Banifazl ◽  
Ali Eslamifar ◽  
Masoomeh Sofian ◽  
Arezoo Aghakhani

Sign in / Sign up

Export Citation Format

Share Document